rs4689273

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_147127.5(EVC2):​c.1006-228C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 152,088 control chromosomes in the GnomAD database, including 10,051 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.35 ( 10051 hom., cov: 33)

Consequence

EVC2
NM_147127.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.293

Publications

3 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 4-5663474-G-A is Benign according to our data. Variant chr4-5663474-G-A is described in ClinVar as Benign. ClinVar VariationId is 671282.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.465 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVC2NM_147127.5 linkc.1006-228C>T intron_variant Intron 8 of 21 ENST00000344408.10 NP_667338.3 Q86UK5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVC2ENST00000344408.10 linkc.1006-228C>T intron_variant Intron 8 of 21 1 NM_147127.5 ENSP00000342144.5 Q86UK5-1
EVC2ENST00000310917.6 linkc.766-228C>T intron_variant Intron 8 of 21 1 ENSP00000311683.2 Q86UK5-2
EVC2ENST00000475313.5 linkn.766-228C>T intron_variant Intron 8 of 22 1 ENSP00000431981.1 A0A0C4DGE7
EVC2ENST00000509670.1 linkn.766-228C>T intron_variant Intron 9 of 22 1 ENSP00000423876.1 E9PFT2

Frequencies

GnomAD3 genomes
AF:
0.349
AC:
53078
AN:
151970
Hom.:
10050
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.394
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.481
Gnomad SAS
AF:
0.355
Gnomad FIN
AF:
0.436
Gnomad MID
AF:
0.401
Gnomad NFE
AF:
0.411
Gnomad OTH
AF:
0.370
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.349
AC:
53084
AN:
152088
Hom.:
10051
Cov.:
33
AF XY:
0.351
AC XY:
26077
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.191
AC:
7904
AN:
41490
American (AMR)
AF:
0.394
AC:
6024
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.382
AC:
1325
AN:
3470
East Asian (EAS)
AF:
0.481
AC:
2485
AN:
5168
South Asian (SAS)
AF:
0.354
AC:
1705
AN:
4816
European-Finnish (FIN)
AF:
0.436
AC:
4613
AN:
10572
Middle Eastern (MID)
AF:
0.384
AC:
112
AN:
292
European-Non Finnish (NFE)
AF:
0.411
AC:
27945
AN:
67962
Other (OTH)
AF:
0.365
AC:
772
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1741
3482
5223
6964
8705
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.389
Hom.:
38006
Bravo
AF:
0.344
Asia WGS
AF:
0.378
AC:
1312
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.53
DANN
Benign
0.27
PhyloP100
-0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4689273; hg19: chr4-5665201; API